Delivering the Promise of Regenerative Medicine Today.
Learn How
Advanced BioHealing is a leader in commercializing living cell therapies, a cornerstone technology in the field of regenerative medicine that repairs damaged human tissue and enables the body to heal itself. The Company currently manufactures and markets Dermagraft®, a bio-engineered skin substitute that assists in restoring damaged tissue and supports the body’s natural healing process. Dermagraft is approved by the FDA for the treatment of diabetic foot ulcers. As one of the first companies to commercialize a living cell product, Advanced BioHealing continues to focus on leveraging its dedicated sales force, scalable cell-based manufacturing, and established reimbursement to expand Dermagraft into additional indications and geographies.
Click here for product indications, safety and full prescribing information.
Driving the evolution of regenerative medicine.
Learn How
Advanced BioHealing is driving the evolution of regenerative medicine by bringing to market innovative treatments with life-changing potential for people struggling with diabetes. Dermagraft, our cell-based therapy for diabetic foot ulcers, utilizes regenerative medicine to advance and stimulate the body’s healing process, resulting in quicker healing times and improved ulcer closure rates. A clinical study has shown that Dermagraft healed more chronic ulcers and healed them faster than conventional therapy alone.
Click here for product indications, safety and full prescribing information.
Providing innovative treatment options for diabetic foot ulcers.
Learn How
Advanced BioHealing aims to deliver new and innovative treatment options to people with diabetes. Of the chronic medical conditions that patients with diabetes are most likely to get, there is a 15 to 25% lifetime risk of developing a diabetic foot ulcer, or a sore on the feet that can occur as a result of peripheral neuropathy, or damage to the nerves, and can severely compromise a patient’s quality of life. If not treated properly, diabetic foot ulcers can result in serious complications. Our cell-based therapy, Dermagraft, is a valuable treatment for diabetic foot ulcers that assists in restoring damaged tissue and is currently indicated for the treatment of certain types of diabetic foot ulcers.
Click here for product indications, safety and full prescribing information.
